Document Detail


Experimental orthostasis elicits sustained hypertension, which can be prevented by sympathetic blockade in the rat.
MedLine Citation:
PMID:  15772525     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Incidence of orthostatic hypertension is estimated at 5% but is even more prevalent in borderline hypertension and autonomic neuropathies. The aim of this study was to develop a potential model to investigate orthostatic hypertension. We used normotensive and hypertensive Wistar rats to analyze responses and diurnal variations of arterial blood pressure, heart rate, temperature, and locomotor activity by telemetry. Orthostatic tests were carried out during 45 degrees head-up tilt (R, repeated 3 times for 5 minutes; or S, sustained for 120 minutes). Hypertension was induced by blockade of nitric oxide synthesis. In normotensives, horizontal control blood pressure was R115.4 +/- 1.4/S113.7 +/- 1.6 mm Hg and heart rate R386.4 +/- 7.0/S377.9 +/- 8.8 bpm. Head-up tilt increased blood pressure by R4.5/S8.4 mm Hg, including a 3.8 mm Hg hydrostatic component. The sustained hypertensive response was prevented by prazosin (10 mg/kgbw) and augmented by a subanesthetic dose of chloralose (26 mg/kgbw). In NO-deprived hypertension, horizontal control blood pressure and heart rate were R138.4 +/- 2.6/S140.3 +/- 2.7 mm Hg and R342.1 +/- 12.0/S346.0 +/- 8.3 bpm, respectively. Tilt increased blood pressure further by R4.2/S9.4 mm Hg. In both normo- and hypertensives, variables exhibited similar diurnal rhythms except for nighttime locomotor activity, reduced from 3.7 +/- 0.4 to 2.8 +/- 0.3 counts/s. These data demonstrate that conscious rats respond to sustained orthostasis with hypertension, probably as a result of increased sympathetic output. Decreasing stress using a subanesthetic dose of chloralose increased this response, reducing the inhibitory effect on hypertensive responses.
Authors:
Gábor Raffai; Márta Mészáros; Márk Kollai; Emil Monos; László Dézsi
Related Documents :
20412265 - The effect of hemodialysis on left ventricular outflow tract gradient.
18708445 - Venous response to orthostatic stress.
6162595 - Orthostatic hypotension after the first administration of prazosin in hypertensive pati...
10678545 - Postural hypotension following n-type ca2+ channel blockade is amplified in experimenta...
8172525 - Intrauterine pressure: comparison of extra vs intra amniotic methods using a transducer...
6419745 - Increase in cerebrospinal fluid pressure in dogs due to coronary agents.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  45     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-03-17     Completed Date:  2005-07-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  354-61     Citation Subset:  IM    
Affiliation:
Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Faculty of Medicine, Budapest, Hungary. raffai@elet2.sote.hu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects,  physiology
Chloralose / pharmacology
Dizziness / complications,  physiopathology,  prevention & control*
Heart Rate / drug effects,  physiology
Hypertension / etiology,  physiopathology,  prevention & control*
Male
Prazosin / pharmacology,  therapeutic use
Rats
Rats, Wistar
Sympatholytics / pharmacology,  therapeutic use*
Chemical
Reg. No./Substance:
0/Sympatholytics; 15879-93-3/Chloralose; 19216-56-9/Prazosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ebelactone B, an inhibitor of extracellular cathepsin A-type enzyme, suppresses platelet aggregation...
Next Document:  Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril ...